Saw where officers from oig visited Cambridge. Interesting
Does not look good.
Does not look good.
-
Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page
Yes, there were some government officials at Biogen this week. with SEC
Related to November statements making stock jump then drop. Not helping our situation.
Related to November statements making stock jump then drop. Not helping our situation.
LOL thanks for the laughI hope no employees bought extra stock or shorted before the announcements.
Many could be in trouble.
Many could be in trouble.